Advanced

EANM-EORTC general recommendations for sentinel node diagnostics in melanoma

Chakera, Annette H.; Hesse, Birger; Burak, Zeynep; Ballinger, James R.; Britten, Allan; Caraco, Corrado; Cochran, Alistair J.; Cook, Martin G.; Drzewiecki, Krzysztof T. and Essner, Richard, et al. (2009) In European Journal of Nuclear Medicine and Molecular Imaging 36(10). p.1713-1742
Abstract
The accurate diagnosis of a sentinel node in melanoma includes a sequence of procedures from different medical specialities (nuclear medicine, surgery, oncology, and pathology). The items covered are presented in 11 sections and a reference list: (1) definition of a sentinel node, (2) clinical indications, (3) radiopharmaceuticals and activity injected, (4) dosimetry, (5) injection technique, (6) image acquisition and interpretation, (7) report and display, ( 8) use of dye, ( 9) gamma probe detection, (10) surgical techniques in sentinel node biopsy, and (11) pathological evaluation of melanoma-draining sentinel lymph nodes. If specific recommendations given cannot be based on evidence from original, scientific studies, referral is given... (More)
The accurate diagnosis of a sentinel node in melanoma includes a sequence of procedures from different medical specialities (nuclear medicine, surgery, oncology, and pathology). The items covered are presented in 11 sections and a reference list: (1) definition of a sentinel node, (2) clinical indications, (3) radiopharmaceuticals and activity injected, (4) dosimetry, (5) injection technique, (6) image acquisition and interpretation, (7) report and display, ( 8) use of dye, ( 9) gamma probe detection, (10) surgical techniques in sentinel node biopsy, and (11) pathological evaluation of melanoma-draining sentinel lymph nodes. If specific recommendations given cannot be based on evidence from original, scientific studies, referral is given to "general consensus" and similar expressions. The recommendations are designed to assist in the practice of referral to, performance, interpretation and reporting of all steps of the sentinel node procedure in the hope of setting state-of-the-art standards for good-quality evaluation of possible spread to the lymphatic system in intermediate-to-high risk melanoma without clinical signs of dissemination. (Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Pathology, Melanoma, Lymphoscintigraphy, Blue dye, Gamma probe, Sentinel node
in
European Journal of Nuclear Medicine and Molecular Imaging
volume
36
issue
10
pages
1713 - 1742
publisher
Springer
external identifiers
  • wos:000270449000023
  • scopus:70350545711
ISSN
1619-7070
DOI
10.1007/s00259-009-1228-4
language
English
LU publication?
yes
id
f58b099e-d823-4181-a077-83a0b93556f9 (old id 1489720)
date added to LUP
2009-10-22 10:22:18
date last changed
2017-12-10 03:39:05
@article{f58b099e-d823-4181-a077-83a0b93556f9,
  abstract     = {The accurate diagnosis of a sentinel node in melanoma includes a sequence of procedures from different medical specialities (nuclear medicine, surgery, oncology, and pathology). The items covered are presented in 11 sections and a reference list: (1) definition of a sentinel node, (2) clinical indications, (3) radiopharmaceuticals and activity injected, (4) dosimetry, (5) injection technique, (6) image acquisition and interpretation, (7) report and display, ( 8) use of dye, ( 9) gamma probe detection, (10) surgical techniques in sentinel node biopsy, and (11) pathological evaluation of melanoma-draining sentinel lymph nodes. If specific recommendations given cannot be based on evidence from original, scientific studies, referral is given to "general consensus" and similar expressions. The recommendations are designed to assist in the practice of referral to, performance, interpretation and reporting of all steps of the sentinel node procedure in the hope of setting state-of-the-art standards for good-quality evaluation of possible spread to the lymphatic system in intermediate-to-high risk melanoma without clinical signs of dissemination.},
  author       = {Chakera, Annette H. and Hesse, Birger and Burak, Zeynep and Ballinger, James R. and Britten, Allan and Caraco, Corrado and Cochran, Alistair J. and Cook, Martin G. and Drzewiecki, Krzysztof T. and Essner, Richard and Even-Sapir, Einat and Eggermont, Alexander M. M. and Stopar, Tanja Gmeiner and Ingvar, Christian and Mihm, Martin C., Jr. and McCarthy, Stanley W. and Mozzillo, Nicola and Nieweg, Omgo E. and Scolyer, Richard A. and Starz, Hans and Thompson, John F. and Trifiro, Giuseppe and Viale, Giuseppe and Vidal-Sicart, Sergi and Uren, Roger and Waddington, Wendy and Chiti, Arturo and Spatz, Alain and Testori, Alessandro},
  issn         = {1619-7070},
  keyword      = {Pathology,Melanoma,Lymphoscintigraphy,Blue dye,Gamma probe,Sentinel node},
  language     = {eng},
  number       = {10},
  pages        = {1713--1742},
  publisher    = {Springer},
  series       = {European Journal of Nuclear Medicine and Molecular Imaging},
  title        = {EANM-EORTC general recommendations for sentinel node diagnostics in melanoma},
  url          = {http://dx.doi.org/10.1007/s00259-009-1228-4},
  volume       = {36},
  year         = {2009},
}